CClinicalTrials.gg
RecruitingNCT06644898Updated Jun 13, 2025

The Effect of Gait Training Using Different Slope Types on Balance in COPD Patients

An interventional study of Level walking training and Downhill walking training in Pulmonary Disease, Chronic Obstructive, sponsored by Acibadem University. Recruiting at 1 site in Turkey. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2025-06-13.

Sponsored by Acibadem University · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Apr 2025; still recruiting 1 year 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

Although COPD is basically a respiratory system disease, its effects are not limited to the respiratory system. In this context, one parameter affected in COPD patients is balance. Recent studies have highlighted the importance of assessing balance and incorporating it into treatment options such as pulmonary rehabilitation. In this context, we aim to diversify the training by using different slope types (downhill, level, uphill) in aerobic exercise training, which is a strong component of pulmonary rehabilitation, and to evaluate the effect of slope type on balance. Testing different types of inclines in aerobic exercise training has the potential to result in different muscular gains. We anticipate that this may result in different balance gains.

Read the detailed description

The convenience sampling method will be used as the sampling method in the research.

In this study, sample size was calculated by a priori power analysis using G*Power 3.1.9.4 software. In the analysis for analysis of variance (ANOVA: repeated measures, between factors) with two factors and repeated measures; effect size f = 0.62 (based on data obtained from previous study, Borghi-Silva et al, 2009), significance level α = 0.05, statistical power (1 - β) = 0.80, number of groups 3, number of measures 2 and correlation coefficient between measures r = 0.5. According to the calculation, it was predicted that the study would reach sufficient statistical power with a total of 24 participants, 8 participants in each group.

There will be three groups in the study: downhill walking, uphill walking, and level walking. The downhill walking and uphill walking groups will be included as the study group and the level walking group will be included as the control group. Participants will be distributed equally to the three groups. Patients will be assigned to these groups by block randomization method using https://www.randomizer.org/ website.

All three groups will be administered a 6-minute walking test at baseline, and participants will be subjected to a common 8-week, twice-weekly treadmill walking training program in which the speed is determined and increased according to the average speed they walk in this test, and in addition to this, the duration is also increased. One session of the training program will consist of warming up, loading, and cooling down on the treadmill.

During the training, the slope of the treadmill will be adjusted to +10 degrees for uphill walking, -10 degrees for downhill walking, and 0 degrees for level walking and will be kept constant for 8 weeks. A special wooden wedge apparatus will be made under the normal treadmill to give -10 downhill slope.

Primary outcome measurements will be made at baseline and at the end of week 8.

02

Conditions studied

  • Pulmonary Disease, Chronic Obstructive

Keywords

  • aerobic exercise, slope, COPD
03

In context

Pulmonary Disease, Chronic Obstructive

4,131 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 697 are open to participants now.

This study's planned enrollment of 51 is below the median of 70 across 2,926 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.

Browse Pulmonary Disease, Chronic Obstructive studies →

Lead sponsor

Acibadem University is the lead sponsor of 210 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Being diagnosed with COPD (A, B, E groups according to GOLD assessment)
  • Ambulate on your own
  • Not having any contraindications for exercise

Exclusion criteria

Exclusion Criteria:

  • Being in GOLD 4 stage in spirometric evaluation
  • Presence of hypoxemia
  • Participation in another pulmonary rehabilitation program within the last 6 months
  • Having an exacerbation in the last 1 month
  • Being diagnosed with additional respiratory disease (asthma, bronchiectasis, etc.)
  • Having had pulmonary surgery
  • Having an orthopedic, neurological or cardiac disease that affects exercise
  • Having uncontrolled hypertension or diabetes
  • Presence of malignancy
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
51 participants (estimated)

Study arms

  • Active comparator
    Level walking

    It will walk at a 0-degree slope (0) throughout the research.

    Other: Level walking training

  • Experimental
    Downhill walking

    It will walk at a 10-degree downhill slope (-10) throughout the research.

    Other: Downhill walking training

  • Experimental
    Uphill walking

    It will walk at a 10-degree uphill slope (+10) throughout the research.

    Other: Uphill walking training

Interventions

  • OtherLevel walking training

    For 8 weeks, level walking training will be done 2 times a week at a slope of 0 degrees.

  • OtherDownhill walking training

    For 8 weeks, downhill walking training will be done 2 times a week at a slope of -10 degrees.

  • OtherUphill walking training

    For 8 weeks, uphill walking training will be done 2 times a week at a slope of +10 degrees.

06

What researchers measure

Primary outcomes

  1. Postural stability test

    The test reflects a person's ability to maintain the center of balance.

    Time frame: Up to 8 weeks.

  2. Limits of Stability (LOS) Test

    The maximum vertical angle that the body can reach while standing without losing balance is called the stability limit.

    Time frame: Up to 8 weeks.

  3. Clinical Test of Sensory Integration of Balance (CTSIB)

    The test assesses how well the person can integrate sensory input to maintain balance.

    Time frame: Up to 8 weeks.

07

Study locations

1 of 1 sites recruiting
  • Bezmialem Vakif University, Department of Physiotherapy and Rehabilitation
    Istanbul, Eyüp Sultan, Turkey
    Recruiting
08

References and documents

Publications

  • Borghi-Silva A, Arena R, Castello V, Simoes RP, Martins LE, Catai AM, Costa D. Aerobic exercise training improves autonomic nervous control in patients with COPD. Respir Med. 2009 Oct;103(10):1503-10. doi: 10.1016/j.rmed.2009.04.015. Epub 2009 May 22. PubMed 19464865 ↗
  • Loughran KJ, Atkinson G, Beauchamp MK, Dixon J, Martin D, Rahim S, Harrison SL. Balance impairment in individuals with COPD: a systematic review with meta-analysis. Thorax. 2020 Jul;75(7):539-546. doi: 10.1136/thoraxjnl-2019-213608. Epub 2020 May 14. PubMed 32409612 ↗
  • Kaygusuz MH, Oral Tapan O, Tapan U, Genc S. Balance impairment and cognitive dysfunction in patients with chronic obstructive pulmonary disease under 65 years. Clin Respir J. 2022 Mar;16(3):200-207. doi: 10.1111/crj.13469. Epub 2022 Jan 26. PubMed 35081270 ↗
  • Jirange P, Vaishali K, Sinha MK, Bairapareddy KC, Alaparthi GK. A Cross-Sectional Study on Balance Deficits and Gait Deviations in COPD Patients. Can Respir J. 2021 Jan 6;2021:6675088. doi: 10.1155/2021/6675088. eCollection 2021. PubMed 33505539 ↗
  • Eymir M, Yakut H, Ozalevli S, Alpaydin AO. Static and dynamic balance impairment and relationship with disease-related factors in patients with chronic obstructive pulmonary disease : A cross-sectional study. Wien Klin Wochenschr. 2021 Nov;133(21-22):1186-1194. doi: 10.1007/s00508-021-01918-8. Epub 2021 Aug 5. PubMed 34351502 ↗
  • Alexander N, Strutzenberger G, Ameshofer LM, Schwameder H. Lower limb joint work and joint work contribution during downhill and uphill walking at different inclinations. J Biomech. 2017 Aug 16;61:75-80. doi: 10.1016/j.jbiomech.2017.07.001. Epub 2017 Jul 11. PubMed 28734544 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06644898
Lead sponsor
Acibadem University
Responsible party
Meryem BEKTAŞ KARAKUŞ (Research Assistant, Acibadem University) — Principal investigator
First posted
Oct 16, 2024
Start date
Apr 9, 2025
Primary completion
Jun 1, 2026 (estimated)
Completion
Jun 1, 2026 (estimated)
Last update
Jun 13, 2025

Study contacts

Meryem Bektaş Karakuş, Research Assistant
Contact
meryem.bektas@acibadem.edu.tr
+90 216 500 4195
Alis Kostanoğlu, Assoc. Prof.
Contact
Akostanoglu@bezmialem.edu.tr

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion